The Enterprise Value as of December 2025 (TTM) for Hemogenyx Pharmaceuticals Plc (HEMO.L) is 37.91M

According to Hemogenyx Pharmaceuticals Plc’s latest financial reports and current stock price. The company's current Enterprise Value is 37.91M. This represents a change of 93.49% compared to the average of 19.59M of the last 4 quarters.

Hemogenyx Pharmaceuticals Plc (HEMO.L) Historical Enterprise Value (quarterly & annually)

How has HEMO.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Hemogenyx Pharmaceuticals Plc over the last ten years is 644.00M. The current 37.91M Enterprise Value has changed 488.69% with respect to the historical average. Over the past ten years (40 quarters), HEMO.L's Enterprise Value was at its highest in in the June 2017 quarter at 3.43B. The Enterprise Value was at its lowest in in the August 2014 quarter at 0.

Hemogenyx Pharmaceuticals Plc (HEMO.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Hemogenyx Pharmaceuticals Plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hemogenyx Pharmaceuticals Plc (HEMO.L) Average Enterprise Value

How has HEMO.L Enterprise Value performed in the past?

The current Enterprise Value of Hemogenyx Pharmaceuticals Plc (HEMO.L) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Hemogenyx Pharmaceuticals Plc (HEMO.L) Enterprise Value vs. Peers

How is HEMO.L’s Enterprise Value compared to its peers?

Hemogenyx Pharmaceuticals Plc’s Enterprise Value is greater than hVIVO plc (5.83M), greater than SkinBioTherapeutics Plc (34.72M), less than Ondine Biomedical Inc. (71.33M), greater than ImmuPharma plc (30.05M), greater than Arecor Therapeutics plc (29.04M), greater than Creo Medical Limited (24.97M), greater than Poolbeg Pharma PLC (16.53M), greater than Kooth plc (27.97M), greater than Aptamer Group plc (19.58M), greater than Sareum Holdings plc (14.40M),

Build a custom stock screener for Hemogenyx Pharmaceuticals Plc (HEMO.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hemogenyx Pharmaceuticals Plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hemogenyx Pharmaceuticals Plc (HEMO.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hemogenyx Pharmaceuticals Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.